Evidence map›Paper›PMID 28849660›Full record

ArticleJournal of proteome research2017

Proteomics Standards Initiative: Fifteen Years of Progress and Future Work.

Eric W Deutsch, Sandra Orchard, Pierre-Alain Binz, Wout Bittremieux, Martin Eisenacher, Henning Hermjakob, Shin Kawano, Henry Lam, Gerhard Mayer, Gerben Menschaert and 7 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Patpat: a public proteomics dataset search framework.Bioinformatics (Oxford, England) · 2023
    Article
  11. Article
  12. Article
  13. Databases and Tools to Investigate Protein-Metabolite Interactions.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  14. The critical role that spectral libraries play in capturing the metabolomics community knowledge.Metabolomics : Official journal of the Metabolomic Society · 2022
    Review
  15. Review
  16. Review
  17. Advances and Utility of the Human Plasma Proteome.Journal of proteome research · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Eric W DeutschInstitute for Systems Biology , Seattle, Washington 98109, United States.ORCID 0000-0001-8732-0928
Sandra OrchardEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) , Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Pierre-Alain BinzCHUV Centre Hospitalier Universitaire Vaudois , 1011 Lausanne, Switzerland.
Wout BittremieuxDepartment of Mathematics and Computer Science, University of Antwerp , Middelheimlaan 1, 2020 Antwerp, Belgium.ORCID 0000-0002-3105-1359
Martin EisenacherMedizinisches Proteom Center (MPC), Ruhr-Universität Bochum , D-44801 Bochum, Germany.
Henning HermjakobEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) , Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Shin KawanoDatabase Center for Life Science, Joint Support Center for Data Science Research, Research Organization of Information and Systems , Kashiwa, Chiba 277-0871, Japan.
Henry LamDivision of Biomedical Engineering, The Hong Kong University of Science and Technology , Clear Water Bay, Hong Kong, P. R. China.
Gerhard MayerMedizinisches Proteom Center (MPC), Ruhr-Universität Bochum , D-44801 Bochum, Germany.
Gerben MenschaertLab of Bioinformatics and Computational Genomics (BioBix), Faculty of Bioscience Engineering, Ghent University , 9000 Ghent, Belgium.
Yasset Perez-RiverolEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) , Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Reza M SalekEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) , Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
David L TabbSA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa.
Stefan TenzerInstitute for Immunology, University Medical Center of the Johannes-Gutenberg University Mainz , 55131 Mainz, Germany.
Juan Antonio VizcaínoEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) , Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Mathias WalzerEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) , Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Andrew R JonesInstitute of Integrative Biology, University of Liverpool , South Wirral L64 4AY, United Kingdom.

Funding

TrainingU54EB020406 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TOGA, ARTHUR W · 2014 to 2018
$12.5M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
Advancing data and metadata standards for proteomics mass spectraR24GM127667 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC · 2017 to 2019
$1.2M
Biotechnology and Biological Sciences Research Council BB/K01997X/1Biotechnology and Biological Sciences Research Council BB/L005239/1Biotechnology and Biological Sciences Research Council BB/L024128/1Biotechnology and Biological Sciences Research Council BB/L024225/1Biotechnology and Biological Sciences Research Council BB/M027635/1Biotechnology and Biological Sciences Research Council BB/N022432/1Biotechnology and Biological Sciences Research Council BB/N022440/1Medical Research Council MR/L01632X/1NIBIB NIH HHS U54 EB020406NIGMS NIH HHS R01 GM087221NIGMS NIH HHS R24 GM127667Wellcome Trust
6 · The paper itself

Abstract

The Proteomics Standards Initiative (PSI) of the Human Proteome Organization (HUPO) has now been developing and promoting open community standards and software tools in the field of proteomics for 15 years. Under the guidance of the chair, cochairs, and other leadership positions, the PSI working groups are tasked with the development and maintenance of community standards via special workshops and ongoing work. Among the existing ratified standards, the PSI working groups continue to update PSI-MI XML, MITAB, mzML, mzIdentML, mzQuantML, mzTab, and the MIAPE (Minimum Information About a Proteomics Experiment) guidelines with the advance of new technologies and techniques. Furthermore, new standards are currently either in the final stages of completion (proBed and proBAM for proteogenomics results as well as PEFF) or in early stages of design (a spectral library standard format, a universal spectrum identifier, the qcML quality control format, and the Protein Expression Interface (PROXI) web services Application Programming Interface). In this work we review the current status of all of these aspects of the PSI, describe synergies with other efforts such as the ProteomeXchange Consortium, the Human Proteome Project, and the metabolomics community, and provide a look at future directions of the PSI.

Indexed as

SoftwareDatabases, ProteinGuidelines as TopicHumansMetabolomicsProteomicsReference Standardsbioinformatics softwaredatabasedata standardmass spectrometrymetabolomicsmolecular interactionsprotein identificationprotein quantificationproteomicsquality control

Identifiers

PMID28849660
PMCPMC5715286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.